AMS.L Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 май 2024 @ 18:35):

Stats
Объем за сегодня	472 735
Средний объем	640 088
Рыночная капитализация	421.32M
EPS	£0 ( 2024-03-16 )
Last Dividend	£1.510 ( 2023-05-18 )
Next Dividend	£0 ( N/A )
P/E	27.74
ATR14	£0.432 (0.22%)

Объем Корреляция

Длинно: 0.00 (neutral)

Кратко: 0.32 (neutral)

Signal:(49.852) Neutral

Advanced Medical Корреляция

10 Самые положительные корреляции
EJFI.L	0.861
PSON.L	0.855
VSL.L	0.845
ALL.L	0.841
NAIT.L	0.84
WIN.L	0.837
MIG.L	0.836
BEZ.L	0.836
LXI.L	0.834
DHSD.L	0.833

10 Самые отрицательные корреляции
TFG.L	-0.877
UD04.L	-0.855
OCTP.L	-0.851
7DIG.L	-0.836
UAI.L	-0.835
FAN.L	-0.818
CALL.L	-0.805

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Advanced Medical Корреляция - Валюта/Сырье

0.72
( moderate )

0.83
( strong )

-0.67
( moderate negative )

0.58
( weak )

-0.17
( neutral )

Advanced Medical Финансовые показатели

Annual	2023
Выручка:	£126.21M
Валовая прибыль:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2023
Выручка:	£126.21M
Валовая прибыль:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2022
Выручка:	£124.33M
Валовая прибыль:	£68.62M (55.19 %)
EPS:	£0.0942

FY	2021
Выручка:	£108.60M
Валовая прибыль:	£61.07M (56.23 %)
EPS:	£0.0813

Financial Reports:

No articles found.

Advanced Medical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0.640 (N/A)	£0 (N/A)	£0 (N/A)	£1.510 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Advanced Medical Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.65 - Stable (33.01%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.380	2011-05-11
Last Dividend	£1.510	2023-05-18
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	26	--
Total Paid Out	£14.14	--
Avg. Dividend % Per Year	0.41%	--
Score	4.24	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.65
Div. Directional Score	9.41	--

Next Divdend (Est)
(2024-09-23)

£0 Estimate 3.72 %

Dividend Stability

0.30 Very Poor

Dividend Score

4.24

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2011	£0.525	0.72%
2012	£0.475	0.51%
2013	£0.540	0.85%
2014	£0.630	0.57%
2015	£0.730	0.58%
2016	£0.850	0.48%
2017	£0.970	0.44%
2018	£1.170	0.38%
2019	£1.400	0.51%
2020	£1.550	0.53%
2021	£1.780	0.73%
2022	£2.01	0.61%
2023	£1.510	0.57%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUPR.L	Dividend Knight	2023-07-13	Quarterly	8	3.25%
KEYS.L	Dividend Knight	2023-09-21	Annually	7	2.29%
CCJI.L	Dividend Knight	2023-07-06	Semi-Annually	9	2.14%
QXT.L	Ex Dividend Junior	2023-07-27	Sporadic	11	0.46%
GHH.L	Dividend Knight	2023-06-22	Annually	27	0.91%
AMC.L	Dividend Knight	2023-06-01	Insufficient data to determine frequency	2	55.57%
TPFG.L	Dividend Knight	2023-09-21	Annually	11	3.16%
MACF.L	Dividend King	2023-09-14	Semi-Annually	32	1.94%
CREI.L	Dividend Knight	2023-07-20	Quarterly	11	3.34%
RUR.L	Dividend Knight	2023-06-22	Sporadic	20	10.67%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.126	1.500	7.48	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0549	1.200	8.17	9.80	[0 - 0.3]
returnOnEquityTTM	0.0653	1.500	-0.386	-0.579	[0.1 - 1]
payoutRatioTTM	0.301	-1.000	6.99	-6.99	[0 - 1]
currentRatioTTM	5.67	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.00	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.79	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00403	-1.500	9.93	-10.00	[0 - 0.6]
interestCoverageTTM	11.88	1.000	6.71	6.71	[3 - 30]
operatingCashFlowPerShareTTM	0.0666	2.00	9.98	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0212	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.00477	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.505	1.000	4.92	4.92	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.16	9.16	[0.1 - 0.6]
cashFlowToDebtRatioTTM	12.42	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.436	0.800	-0.424	-0.339	[0.5 - 2]
Total Score				12.17

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.86	1.000	7.49	0	[1 - 100]
returnOnEquityTTM	0.0653	2.50	-0.248	-0.579	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0212	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	1.167	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0666	2.00	9.98	10.00	[0 - 30]
payoutRatioTTM	0.301	1.500	6.99	-6.99	[0 - 1]
pegRatioTTM	56.85	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.115	1.000	9.64	0	[0.1 - 0.5]
Total Score				6.65

Advanced Medical

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.